Mart Saarma News Today

A research group at the University of Helsinki and its partners have found a promising drug candidate for the treatment of amyotrophic lateral sclerosis (ALS).

The Minerva Foundations Medix Prize for 2022 awarded to a research group from the University of Helsinki. The research group produced new data on the modes of action of antidepressants. Patients suffering from depression benefit from serotonin-increasing medications. This finding has resulted in a conclusion, commonly accepted for decades, that the primary cause of depression is a depletion in serotonin.

Press release content from Business Wire. The AP news staff was not involved in its creation.

For the latest World of Genomics, we head over to Estonia – famous for its dense woodlands, charming historic sites and over 2,000 islands.